Skip to main content
. Author manuscript; available in PMC: 2013 Sep 10.
Published in final edited form as: AIDS Behav. 2013 Jan;17(1):127–141. doi: 10.1007/s10461-012-0272-4

Table 4.

Antiretroviral (ARV) characteristics grouped by ARV type

ARV code Name of ARV No. of readings No. of subjects Person months ARV type No. of drugs
ENF Enfuvirtide (Fuzeon, ENF, T-20) 499 5 4.07 FI 1
EFV Efavirenz (Sustiva) 37,537 290 5.89 NNRTI 1
NVP Nevirapine (Viramune) 29,833 156 4.95 NNRTI 1
ATR Atripla (efavirenz + TDF+FTC) 5,943 27 9.37 NNRTI 3
DLV Delavirdine (Rescriptor) 5,457 42 4.29 NNRTI 1
CBV Combivir (AZT + 3TC) 37,424 240 3.82 NRTI 2
TRZ Trizivir (AZT+3TC + ABC) 20,924 128 4.01 NRTI 3
ABC Abacavir (Ziagen) 16,233 106 3.79 NRTI 1
D4T Stavudine (Zerit) 14,260 103 3.61 NRTI 1
3TC Lamivudine (Epivir) 13,895 126 3.48 NRTI 1
DDI Didanosine (Videx) 8,101 81 3.37 NRTI 1
AZT Zidovudine (Retrovir, AZT, ZDV) 5,758 37 3.66 NRTI 1
ADF Adefovir (ADF) 1,363 20 3.37 NRTI 1
DDC Zalcitabine (Hivid) 949 9 3.17 NRTI 1
EPZ Epzicom (ABC + 3TC) 713 17 2.68 NRTI 2
TDF Tenofovir (Viread) 3,656 48 3.46 NtRTI 1
TRU Truvada (FTC + TDF) 2,969 48 3.11 NtRTI 2
FTC Emtricitabine (Emtriva) 2,103 23 3.87 NtRTI 1
NFV Nelfinavir (Viracept, NFV) 77,244 406 4.62 PI 1
LPV Lopinavir/Ritonavir (Kaletra) 58,128 356 4.47 PI 2
IDV Indinavir (Crixivan, IDV) 36,240 171 4.15 PI 1
ATZ Atazanavir (Reyataz) 28,276 215 6.39 PI 1
RTV Ritonavir (Norvir, RTV) 20,506 148 5.51 PI 1
SQV Saquinavir (Fortovase, SQV) 16,697 88 6.04 PI 1
FOR Saquinavir (Invirase, SQV) 7,509 71 3.36 PI 1
FPV Fosamprenavir (Lexiva, Telzir, FPV) 6,629 44 6.31 PI 1
APV Amprenavir (Agenerase) 2,522 30 2.88 PI 1
DRV Darunavir (Prezista) 1,870 6 9.00 PI 1
TPV Tipranavir (Aptivus, TPV) 1,247 5 7.32 PI 1
PLC Placebo 12,266 54 6.20
OTH Other drugs 1,236 28 1.55
Total 477,987

Note: “–” indicates the data are not available